Over nearly two decades of development, ADSS has established a fully integrated and independent R&D and manufacturing system, forming a solid foundation for scalable innovation and long-term technological leadership in medical aesthetic devices.
ADSS Completes an End-to-End R&D and Manufacturing Chain for Medical Aesthetic Devices
Since its establishment, ADSS has consistently positioned the integration of research & development and manufacturing as the core of its long-term development strategy. Rather than relying on external suppliers or fragmented production chains, the company has pursued a vertically integrated model to ensure technological independence, system stability, and product consistency.
In the early stages of development, ADSS began building standardized management and development systems to support scalable growth. The acquisition of ISO 9001 certification in 2006 and ISO 13485 medical device quality certification in 2007 laid a solid regulatory and operational foundation, enabling the company to align internal processes with international medical device standards at an early stage.
As product complexity and technological depth continued to increase, ADSS further consolidated its capabilities by establishing an industrial park in Gu’an, covering 60 acres with a construction area exceeding 36,000 square meters. This facility integrates R&D, precision manufacturing, testing, and quality control into a unified operational system.
Today, ADSS has achieved full in-house development across industrial design, electronic control systems, software platforms, laser sources, and system integration, covering more than 20 product series. This end-to-end independent technology chain supports continuous innovation, efficient iteration, and long-term competitiveness in global medical aesthetic markets.
Come back
